Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Wiener

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Pyrazole-based arylalkyne cathepsin S inhibitors. Part III: modification of P4 regionJohn J M Wiener, Alvah Tyson Wickboldt, Steven Nguyen, et al.
Scientific Reports|July 5, 2023
Cultural determinants of the gap between self-estimated navigation ability and wayfinding performance: evidence from 46 countriesS Walkowiak, A Coutrot, M Hegarty, et al.
Nature|March 31, 2022
Entropy of city street networks linked to future spatial navigation abilityA Coutrot, E Manley, S Goodroe, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: Modification of P3, P4, and P5 regionsJohn J M Wiener, Alvah T Wickboldt, Danielle K Wiener, et al.
Journal of Chemical Information and Modeling|March 1, 2019
Accelerating Lead Identification by High Throughput Virtual Screening: Prospective Case Studies from the Pharmaceutical IndustryKelly L Damm-Ganamet, Nidhi Arora, Stephane Becart, et al.
European Journal of Pharmacology|May 22, 2020
Selective inhibition of peripheral cathepsin S reverses tactile allodynia following peripheral nerve injury in mouseWilliam A Eckert, John J M Wiener, Hui Cai, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2007
Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysisLaurent Gomez, Michael D Hack, Jiejun Wu, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2007
Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strainsJohn J M Wiener, Laurent Gomez, Hariharan Venkatesan, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2012
Azabenzthiazole inhibitors of leukotriene A₄ hydrolaseVirginia M Tanis, Genesis M Bacani, Jonathan M Blevitt, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory ActivityMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Pyrazole-based arylalkyne cathepsin S inhibitors. Part III: modification of P4 regionJohn J M Wiener, Alvah Tyson Wickboldt, Steven Nguyen, et al.
Scientific Reports|July 5, 2023
Cultural determinants of the gap between self-estimated navigation ability and wayfinding performance: evidence from 46 countriesS Walkowiak, A Coutrot, M Hegarty, et al.
Nature|March 31, 2022
Entropy of city street networks linked to future spatial navigation abilityA Coutrot, E Manley, S Goodroe, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: Modification of P3, P4, and P5 regionsJohn J M Wiener, Alvah T Wickboldt, Danielle K Wiener, et al.
Journal of Chemical Information and Modeling|March 1, 2019
Accelerating Lead Identification by High Throughput Virtual Screening: Prospective Case Studies from the Pharmaceutical IndustryKelly L Damm-Ganamet, Nidhi Arora, Stephane Becart, et al.
European Journal of Pharmacology|May 22, 2020
Selective inhibition of peripheral cathepsin S reverses tactile allodynia following peripheral nerve injury in mouseWilliam A Eckert, John J M Wiener, Hui Cai, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2007
Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysisLaurent Gomez, Michael D Hack, Jiejun Wu, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2007
Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strainsJohn J M Wiener, Laurent Gomez, Hariharan Venkatesan, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2012
Azabenzthiazole inhibitors of leukotriene A₄ hydrolaseVirginia M Tanis, Genesis M Bacani, Jonathan M Blevitt, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory ActivityMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Pageof 9